Objective: To describe pharmacy-supported transition-of-care (TOC) interventions and determine their effect on 30-day all-cause readmissions. Data Sources: MEDLINE/PubMed, EMBASE, International Pharmaceutical Abstracts, ABI Inform Complete, PsychINFO, Web of Science, Academic Search Complete, CINHAL, Cochrane library, OIASTER, ProQuest Dissertations & Theses, ClinicalTrials.gov, and relevant websites were searched from January 1, 1995, to December 31, 2015. Study Selection and Data Extraction: PICOS+E criteria were utilized. Eligible studies reported pharmacy-supported TOC interventions compared with usual care in adult patients discharged to home within the United States. Studies were required to evaluate postdischarge outcomes (eg, rate of readmissions, hospital utilization). Randomized controlled trials, cohort studies, or controlled before-and-after studies were included. Two reviewers independently extracted data and evaluated study quality. Data Synthesis: A total of 56 articles were included in the systematic review (n = 61 858), of which 32 reported 30-day all-cause readmissions and were included in the meta-analysis. A taxonomy was developed to categorize targeted patients, intervention types, and pharmacy personnel as sole intervener. The meta-analysis demonstrated about a 32% reduction in the odds of readmission (odds ratio [OR] = 0.68; 95% CI = 0.61 to 0.75) observed for pharmacy-supported TOC interventions compared with usual care. Heterogeneity was identified (I2 = 55%; P < 0.001). A stratified meta-analysis showed that interventions with patient-centered follow-up reduced 30-day readmissions relative to studies without follow-up (OR = 0.70; CI = 0.63 to 0.78). Conclusions: Pharmacy-supported TOC programs were associated with a significant reduction in the odds of 30-day readmissions.
ZuckermanRBSheingoldSHOravEJRuhterJEpsteinAM.Readmissions, observation, and the hospital readmissions reduction program. N Engl J Med. 2016;374:1543-1551. doi:10.1056/NEJMsa1513024
4.
van WalravenCBennettCJenningsAAustinPCForsterAJ.Proportion of hospital readmissions deemed avoidable: a systematic review. CMAJ. 2011;183:E391-E402. doi:10.1503/cmaj.101860
JencksSFWilliamsMVColemanEA.Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360:1418-1428. doi:10.1056/NEJMsa0803563
7.
Bonnet-ZamponiDd’ArailhLKonratCet al. Drug-related readmissions to medical units of older adults discharged from acute geriatric units: results of the Optimization of Medication in AGEd multicenter randomized controlled trial. J Am Geriatr Soc. 2013;61:113-121. doi:10.1111/jgs.12037
8.
WintersteinAGSauerBCHeplerCDPooleC.Preventable drug-related hospital admissions. Ann Pharmacother. 2002;36:1238-1248. doi:10.1345/aph.1A225
9.
GuthrieBMakubateBHernandez-SantiagoVDreischulteT.The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995-2010. BMC Med. 2015;13:74. doi:10.1186/s12916-015-0322-7
10.
LeendertseAJEgbertsACStokerLJvan den BemtPM.Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;168:1890-1896. doi:10.1001/archinternmed.2008.3
11.
HowardRLAveryAJSlavenburgSet al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol. 2007;63:136-147. doi:10.1111/j.1365-2125.2006.02698.x
12.
ForsterAJMurffHJPetersonJFGandhiTKBatesDW.The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med. 2003;138:161-167. doi:10.7326/0003-4819-138-3-200302040-00007
13.
ForsterAJMurffHJPetersonJFGandhiTKBatesDW.Adverse drug events occurring following hospital discharge. J Gen Intern Med. 2005;20:317-323. doi:10.1111/j.1525-1497.2005.30390.x
14.
KanaanAODonovanJLDuchinNPet al. Adverse drug events after hospital discharge in older adults: types, severity, and involvement of Beers Criteria Medications. J Am Geriatr Soc. 2013;61:1894-1899. doi:10.1111/jgs.12504
15.
BellCMBrenerSSGunrajNet al. Association of ICU or hospital admission with unintentional discontinuation of medications for chronic diseases. JAMA. 2011;306:840-847. doi:10.1001/jama.2011.1206
16.
ScalesDCFischerHDLiPet al. Unintentional continuation of medications intended for acute illness after hospital discharge: a population-based cohort study. J Gen Intern Med. 2016;31:196-202. doi:10.1007/s11606-015-3501-5
FallisBADhallaIAKlemensbergJBellCM.Primary medication non-adherence after discharge from a general internal medicine service. PLoS One. 2013;8:e61735. doi:10.1371/journal.pone.0061735
19.
HajjarERHanlonJTSloaneRJet al. Unnecessary drug use in frail older people at hospital discharge. J Am Geriatr Soc. 2005;53:1518-1523. doi:10.1111/j.1532-5415.2005.53523.x
20.
LazarouJPomeranzBHCoreyPN.Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200-1205. doi:10.1001/jama.279.15.1200
21.
ClassenDCPestotnikSLEvansRSLloydJFBurkeJP.Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. JAMA. 1997;277:301-306. doi:10.1001/jama.1997.03540280039031
22.
Garcia-CaballosMRamos-DiazFJimenez-MoleonJJBueno-CavanillasA.Drug-related problems in older people after hospital discharge and interventions to reduce them. Age Ageing. 2010;39:430-438. doi:10.1093/ageing/afq045
23.
IsettsBJBrummelARde OliveiraDRMoenDW.Managing drug-related morbidity and mortality in the patient-centered medical home. Med Care. 2012;50:997-1001. doi:10.1097/MLR.0b013e31826ecf9a
24.
DaviesECGreenCFMottramDRRowePHPirmohamedM.Emergency re-admissions to hospital due to adverse drug reactions within 1 year of the index admission. Br J Clin Pharmacol. 2010;70:749-755. doi:10.1111/j.1365-2125.2010.03751.x
25.
LeapeLLCullenDJClappMDet al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282:267-270. doi:10.1001/jama.282.3.267
26.
KucukarslanSNPetersMMlynarekMNafzigerDA.Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003;163:2014-2018. doi:10.1001/archinte.163.17.2014
27.
American Society of Health-System Pharmacists. ASHP statement on the pharmacist’s role in medication reconciliation. Am J Health Syst Pharm. 2013;70:453-456. doi:10.2146/sp120009
28.
BradleyEHCurryLHorwitzLIet al. Contemporary evidence about hospital strategies for reducing 30-day readmissions: a national study. J Am Coll Cardiol. 2012;60:607-614. doi:10.1016/j.jacc.2012.03.067
29.
KwanJLLoLSampsonMShojaniaKG.Medication reconciliation during transitions of care as a patient safety strategy: a systematic review. Ann Intern Med. 2013;158(5, pt 2):397-403. doi:10.7326/0003-4819-158-5-201303051-00006
30.
EnsingHTStuijtCCvan den BemtBJet al. Identifying the optimal role for pharmacists in care transitions: a systematic review. J Manag Care Spec Pharm. 2015;21:614-636. doi:http://dx.doi.org/10.18553/jmcp.2015.21.8.614
31.
HammadEABaleAWrightDJBhattacharyaD.Pharmacy led medicine reconciliation at hospital: a systematic review of effects and costs. Res Social Adm Pharm. 2017;13:300-312. doi:10.1016/j.sapharm.2016.04.007
32.
MekonnenABMcLachlanAJBrienJA.Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis. BMJ Open. 2016;6:e010003. doi:10.1136/bmjopen-2015-010003
SpinewineAClaeysCFoulonVChevalierP.Approaches for improving continuity of care in medication management: a systematic review. Int J Qual Health Care. 2013;25:403-417. doi:10.1093/intqhc/mzt032
35.
MoherDLiberatiATetzlaffJAltmanDG.Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264-269, w64. doi:10.7326/0003-4819-151-4-200908180-00135
36.
SterneJACHigginsJPTReevesBC; On Behalf of the Development Group for ACROBAT-NRSI. A Cochrane risk of bias assessment tool: for non-randomized studies of interventions (ACROBAT-NRSI), version 1.0.0. http://www.riskofbias.info/. Accessed May 17, 2017.
37.
HigginsJPTAltmanDGStearneJAC, eds. Assessing risk of bias in included studies. In: HigginsJPTGreenS, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. http://www.cochrane-handbook.org. Accessed January 12, 2017.
38.
EnglanderHMichaelsLChanBKansagaraD.The care transitions innovation (C-TraIn) for socioeconomically disadvantaged adults: results of a cluster randomized controlled trial. J Gen Intern Med. 2014;29:1460-1467. doi:10.1007/s11606-014-2903-0
39.
KripalaniSRoumieCLDalalAKet al. Effect of a pharmacist intervention on clinically important medication errors after hospital discharge: a randomized trial. Ann Intern Med. 2012;157:1-10. doi:10.7326/0003-4819-157-1-201207030-00003
40.
BlandJMAltmanDG.Statistics notes: the odds ratio. BMJ. 2000;320:1468.
41.
HigginsJPThompsonSGDeeksJJAltmanDG.Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560. doi:10.1136/bmj.327.7414.557
42.
BeggCBMazumdarM.Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-1101. doi:10.2307/2533446
43.
EggerMDavey SmithGSchneiderMMinderC.Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634. doi:https://doi.org/10.1136/bmj.315.7109.629
44.
AndereggSVWilkinsonSTCouldryRJGrauerDWHowserE.Effects of a hospitalwide pharmacy practice model change on readmission and return to emergency department rates. Am J Health Syst Pharm. 2014;71:1469-1479. doi:10.2146/ajhp130686
45.
AndersonSLMarrsJCVande GriendJPHanrattyR.Implementation of a clinical pharmacy specialist-managed telephonic hospital discharge follow-up program in a patient-centered medical home. Popul Health Manag. 2013;16:235-241. doi:10.1089/pop.2012.0070
46.
ArnoldMEBuysLFullasF.Impact of pharmacist intervention in conjunction with outpatient physician follow-up visits after hospital discharge on readmission rate. Am J Health Syst Pharm. 2015;72(11, suppl 1):S36-S42. doi:10.2146/sp150011
47.
BoothKAVinciLMOylerJLPincavageAT.Using a resident discharge clinic for resident education and patient care: a feasibility study. J Grad Med Educ. 2014;6:536-540. doi:10.4300/JGME-D-13-00313.1
48.
BudimanTSnodgrassKKomatsu ChangA.Evaluation of pharmacist medication education and post-discharge follow-up in reducing readmissions in patients with ST-segment elevation myocardial infarction (STEMI). Ann Pharmacother. 2016;50:118-124. doi:10.1177/1060028015620425
ChristySSinBGimS.Impact of an integrated pharmacy transitions of care pilot program in an urban hospital. J Pharm Pract. 2016;29:490-494. doi:10.1177/0897190014568674
51.
DedhiaPKravetSBulgerJet al. A quality improvement intervention to facilitate the transition of older adults from three hospitals back to their homes. J Am Geriatr Soc. 2009;57:1540-1546. doi:10.1111/j.1532-5415.2009.02430.x
52.
DudasVBookwalterTKerrKMPantilatSZ.The impact of follow-up telephone calls to patients after hospitalization. Am J Med. 2001;111(9b):26s-30s.
53.
FarrisKBCarterBLXuYet al. Effect of a care transition intervention by pharmacists: an RCT. BMC Health Serv Res. 2014;14:406. doi:10.1186/1472-6963-14-406
54.
FeraTAndersonCKanelKTRamusivichDL.Role of a care transition pharmacist in a primary care resource center. Am J Health Syst Pharm. 2014;71:1585-1590. doi:10.2146/ajhp130684
55.
GilMMikaitisDKShierGJohnsonTJSimsS.Impact of a combined pharmacist and social worker program to reduce hospital readmissions. J Manag Care Pharm. 2013;19:558-563. doi:http://dx.doi.org/10.18553/jmcp.2013.19.7.558
56.
GunadiSUpfieldSPhamNDYeaJSchmiedebergMBStahmerGD.Development of a collaborative transitions-of-care program for heart failure patients. Am J Health Syst Pharm. 2015;72:1147-1152. doi:10.2146/ajhp140563
57.
HawesEMMaxwellWDWhiteSFMangunJLinFC.Impact of an outpatient pharmacist intervention on medication discrepancies and health care resource utilization in posthospitalization care transitions. J Prim Care Community Health. 2014;5:14-18. doi:10.1177/2150131913502489
58.
JacksonCTTrygstadTKDeWaltDADuBardCA.Transitional care cut hospital readmissions for North Carolina Medicaid patients with complex chronic conditions. Health Aff (Millwood). 2013;32:1407-1415. doi:10.1377/hlthaff.2013.0047
59.
KellerSCCiuffetelliDBilkerWet al. The impact of an infectious diseases transition service on the care of outpatients on parenteral antimicrobial therapy. J Pharm Technol. 2013;29:205-214. doi:10.1177/8755122513500922
60.
KilcupMSchultzDCarlsonJWilsonB.Postdischarge pharmacist medication reconciliation: impact on readmission rates and financial savings. J Am Pharm Assoc. 2013;53:78-84. doi:10.1331/JAPhA.2013.11250
61.
KirkhamHSClarkBLPaynterJLewisGHDuncanI.The effect of a collaborative pharmacist-hospital care transition program on the likelihood of 30-day readmission. Am J Health Syst Pharm. 2014;71:739-745. doi:10.2146/ajhp130457
62.
PhatakAPrusiRWardBet al. Impact of pharmacist involvement in the transitional care of high-risk patients through medication reconciliation, medication education, and postdischarge call-backs (IPITCH Study). J Hosp Med. 2016;11:39-44. doi:10.1002/jhm.2493
63.
PinelliNRClarkLMCarringtonACCarringtonJLMalinzakLPatelA.Pharmacist managed diabetes and cardiovascular risk reduction clinic in kidney transplant recipients: bridging the gap in care transition. Diabetes Res Clin Pract. 2014;106:e64-e67. doi:10.1016/j.diabres.2014.09.034
64.
PowersJSCoxZYoungJHowellMDiSalvoT.Critical pathways: implementation of the Coleman Care Transitions Program in individuals hospitalized with congestive heart failure. J Am Geriatr Soc. 2014;62:2442-2444. doi:10.1111/jgs.13174
65.
RyanJAndrewsRBarryMBet al. Preventability of 30-day readmissions for heart failure patients before and after a quality improvement initiative. Am J Med Qual. 2014;29:220-226. doi:10.1177/1062860613496135
66.
SebaalyJParsonsLBPilchNABullingtonWHayesGLEasterlingH.Clinical and financial impact of pharmacist involvement in discharge medication reconciliation at an academic medical center: a prospective pilot study. Hosp Pharm. 2015;50:505-513. doi:10.1310/hpj5006-505
67.
ShayaFTChirikovVVRochesterCZaghabRWKucharskiKC.Impact of a comprehensive pharmacist medication-therapy management service. J Med Econ. 2015;18:828-837. doi:10.3111/13696998.2015.1052463
68.
ShcherbakovaNTeresoG.Clinical pharmacist home visits and 30-day readmissions in Medicare Advantage beneficiaries. J Eval Clin Pract. 2016;22:363-368. doi:10.1111/jep.12495
69.
StillKLDavisAKChilipkoAAJenkosolANorwoodDK.Evaluation of a pharmacy-driven inpatient discharge counseling service: impact on 30-day readmission rates. Consult Pharm. 2013;28:775-785. doi:10.4140/TCP.n.2013.775
70.
StrangesPMMarshallVDWalkerPCHallKEGriffithDKRemingtonT.A multidisciplinary intervention for reducing readmissions among older adults in a patient-centered medical home. Am J Manag Care. 2015;21:106-113.
71.
TedescoGWMcConahaJLSkomoMLHigginbothamSK.A pharmacist’s impact on 30-day readmission rates when compared to the current standard of care within a patient-centered medical home: a pilot study. J Pharm Pract. 2016;29:368-373. doi:10.1177/0897190014568671
72.
TruongJTBackesAC.The impact of a continuum of care resident pharmacist on heart failure readmissions and discharge instructions at a community hospital. SAGE Open Med. 2015;3:2050312115577986. doi:10.1177/2050312115577986
73.
WalkerPCBernsteinSJJonesJNet al. Impact of a pharmacist-facilitated hospital discharge program: a quasi-experimental study. Arch Intern Med. 2009;169:2003-2010. doi:10.1001/archinternmed.2009.398
74.
PalABabbottSWilkinsonST.Can the targeted use of a discharge pharmacist significantly decrease 30-day readmissions?Hosp Pharm. 2013;48:380-388. doi:10.1310/hpj4805-380
75.
CalvertSBKramerJMAnstromKJKaltenbachLAStaffordJAAllen LaPointeNM.Patient-focused intervention to improve long-term adherence to evidence-based medications: a randomized trial. Am Heart J. 2012;163:657-65.e1. doi:10.1016/j.ahj.2012.01.019
76.
DaleyCM.A hybrid transitional care program. Crit Pathw Cardiol. 2010;9:231-234. doi:10.1097/HPC.0b013e3182018838
77.
EisenhowerC.Impact of pharmacist-conducted medication reconciliation at discharge on readmissions of elderly patients with COPD. Ann Pharmacother. 2014;48:203-208. doi:10.1177/1060028013512277
78.
GilmoreVEfirdLFuDLeBlancYNesbitTSwarthoutM.Implementation of transitions-of-care services through acute care and outpatient pharmacy collaboration. Am J Health Syst Pharm. 2015;72:737-744. doi:10.2146/ajhp140504
79.
HoPMLambert-KerznerACareyEPet al. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial. JAMA Intern Med. 2014;174:186-193. doi:10.1001/jamainternmed.2013.12944
80.
ImbergAJSwanoskiMTRenierCMSorensenTD.Maximizing medication therapy management services through a referral initiative. Am J Health Syst Pharm. 2012;69:1234-1239. doi:10.2146/ajhp110511
81.
JackBWChettyVKAnthonyDet al. A reengineered hospital discharge program to decrease rehospitalization: a randomized trial. Ann Intern Med. 2009;150:178-187.
82.
KoehlerBERichterKMYoungbloodLet al. Reduction of 30-day postdischarge hospital readmission or emergency department (ED) visit rates in high-risk elderly medical patients through delivery of a targeted care bundle. J Hosp Med. 2009;4:211-218. doi:10.1002/jhm.427
83.
KogutSJGoldsteinECharbonneauCJacksonAPatryG.Improving medication management after a hospitalization with pharmacist home visits and electronic personal health records: an observational study. Drug Healthc Patient Saf. 2014;6:1-6. doi:10.2147/DHPS.S56574
84.
LiptonHLBirdJA.The impact of clinical pharmacists’ consultations on geriatric patients’ compliance and medical care use: a randomized controlled trial. Gerontologist. 1994;34:307-315. doi:10.1093/geront/34.3.307
85.
MusgraveCRPilchNATaberDJet al. Improving transplant patient safety through pharmacist discharge medication reconciliation. Am J Transplant. 2013;13:796-801. doi:10.1111/ajt.12070
86.
PaquinAMSalowMRudolphJL.Pharmacist calls to older adults with cognitive difficulties after discharge in a tertiary Veterans Administration Medical Center: a quality improvement program. J Am Geriatr Soc. 2015;63:571-577. doi:10.1111/jgs.13315
87.
RainvilleEC.Impact of pharmacist interventions on hospital readmissions for heart failure. Am J Health Syst Pharm. 1999;56:1339-1342.
88.
ReichardJSSavageSEckelSF.Pharmacy-initiated transitions of care services: an opportunity to impact patient satisfaction. Hosp Pharm. 2015;50:911-917. doi:10.1310/hpj5010-911
89.
RiceYBBarnesCARastogiRHillstromTJSteinkelerCN.Tackling 30-day, all-cause readmissions with a patient-centered transitional care bundle. Popul Health Manag. 2016;19:56-62. doi:10.1089/pop.2014.0163
90.
SchilligJKaatzSHudsonMKrolGDSzandzikEGKalusJS.Clinical and safety impact of an inpatient pharmacist-directed anticoagulation service. J Hosp Med. 2011;6:322-328. doi:10.1002/jhm.910
91.
SchnipperJLHamannCNdumeleCDet al. Effect of an electronic medication reconciliation application and process redesign on potential adverse drug events: a cluster-randomized trial. Arch Intern Med. 2009;169:771-780. doi:10.1001/archinternmed.2009.51
92.
SchnipperJLKirwinJLCotugnoMCet al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med. 2006;166:565-571. doi:10.1001/archinte.166.5.565
93.
SetterSMCorbettCFNeumillerJJGatesBJSclarDASonnettTE.Effectiveness of a pharmacist-nurse intervention on resolving medication discrepancies for patients transitioning from hospital to home health care. Am J Health Syst Pharm. 2009;66:2027-2031. doi:10.2146/ajhp080582
94.
ShahMNorwoodCAFariasSIbrahimSChongPHFogelfeldL.Diabetes transitional care from inpatient to outpatient setting: pharmacist discharge counseling. J Pharm Pract. 2013;26:120-124. doi:10.1177/0897190012451907
95.
SidesEGZimmerLOWilsonLet al. Medication coaching program for patients with minor stroke or TIA: a pilot study. BMC Public Health. 2012;12:549. doi:10.1186/1471-2458-12-549
96.
TrangJMartinezAAslamSDuongMT.Pharmacist advancement of transitions of care to home (PATCH) service. Hosp Pharm. 2015;50:994-1002. doi:10.1310/hpj5011-994
97.
TrillerDMHamiltonRA.Effect of pharmaceutical care services on outcomes for home care patients with heart failure. Am J Health Syst Pharm. 2007;64:2244-2249. doi:10.2146/ajhp050492
98.
ColemanEASmithJDFrankJCEilertsenTBThiareJNKramerAM.Development and testing of a measure designed to assess the quality of care transitions. Int J Integr Care. 2002;2(2):1-9.
99.
BallingLErstadBLWeibelK.Impact of a transition-of-care pharmacist during hospital discharge. J Am Pharm Assoc (2003). 2015;55:44344-8. doi:10.1331/JAPhA.2015.14087
100.
NesterTMHaleLS.Effectiveness of a pharmacist-acquired medication history in promoting patient safety. Am J Health Syst Pharm. 2002;59:2221-2225.
DonzeJDWilliamsMVRobinsonEJet al. International validity of the HOSPITAL score to predict 30-day potentially avoidable hospital readmissions. JAMA Intern Med. 2016;176:496-502. doi:10.1001/jamainternmed.2015.8462
104.
DeeksJJHigginsJPTAltmanDG, eds; On Behalf of the Cochrane Statistical Methods Group. Analysing data and undertaking meta-analyses. In: HigginsJPTGreenS, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. 2011:chap 9. http://www.handbook.cochrane.org. Accessed January 12, 2017.
105.
CohenJ. Statistical Power Analysis for the Behavioral Sciences. 2nd ed.Hillsdale, NJ: Lawrence Erlbaum; 1988:567.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
